| abstract |
The present disclosure provides a method for treating a subject having a tumor derived from, eg, non-small cell lung cancer (NSCLC), the method comprising administering to the subject (a) chemotherapy, (b) ) an anti-PD-1 antibody or a combination of an anti-PD-L1 antibody and (c) an anti-CTLA-4 antibody, wherein the chemotherapy is administered for less than a standard period of time. |